ZYNE
Charles Schwab’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-37,596
| Closed | -$47.7K | – | 3608 |
|
|
2023
Q3 | $47.7K | Hold |
37,596
| – | – | ﹤0.01% | 3410 |
|
|
2023
Q2 | $12.3K | Hold |
37,596
| – | – | ﹤0.01% | 3589 |
|
|
2023
Q1 | $16.2K | Hold |
37,596
| – | – | ﹤0.01% | 3521 |
|
|
2022
Q4 | $19.9K | Hold |
37,596
| – | – | ﹤0.01% | 3502 |
|
|
2022
Q3 | $28K | Hold |
37,596
| – | – | ﹤0.01% | 3451 |
|
|
2022
Q2 | $43K | Buy |
+37,596
| New | +$43K | ﹤0.01% | 3413 |
|
|
2022
Q1 | – | Sell |
-18,093
| Closed | -$53K | – | 3639 |
|
|
2021
Q4 | $53K | Hold |
18,093
| – | – | ﹤0.01% | 3509 |
|
|
2021
Q3 | $77K | Hold |
18,093
| – | – | ﹤0.01% | 3408 |
|
|
2021
Q2 | $96K | Buy |
+18,093
| New | +$96K | ﹤0.01% | 3292 |
|
|
2020
Q2 | – | Sell |
-57,333
| Closed | -$220K | – | 3374 |
|
|
2020
Q1 | $220K | Hold |
57,333
| – | – | ﹤0.01% | 2989 |
|
|
2019
Q4 | $347K | Hold |
57,333
| – | – | ﹤0.01% | 2940 |
|
|
2019
Q3 | $434K | Buy |
57,333
+4,645
| +9% | +$35.2K | ﹤0.01% | 2859 |
|
|
2019
Q2 | $714K | Buy |
+52,688
| New | +$714K | ﹤0.01% | 2686 |
|
|
2018
Q2 | – | Sell |
-19,200
| Closed | -$167K | – | 3162 |
|
|
2018
Q1 | $167K | Hold |
19,200
| – | – | ﹤0.01% | 3012 |
|
|
2017
Q4 | $241K | Hold |
19,200
| – | – | ﹤0.01% | 2941 |
|
|
2017
Q3 | $161K | Hold |
19,200
| – | – | ﹤0.01% | 3038 |
|
|
2017
Q2 | $326K | Buy |
+19,200
| New | +$326K | ﹤0.01% | 2833 |
|